-
1 Comment
Hybio Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 12.2% below its 200 day moving average.
From a valuation standpoint, the stock is 31.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.6.
Hybio Pharmaceutical Co., Ltd's total revenue rose by 133.2% to $247M since the same quarter in the previous year.
Its net income has increased by 105.6% to $9M since the same quarter in the previous year.
Finally, its free cash flow grew by 84.0% to $-53M since the same quarter in the previous year.
Based on the above factors, Hybio Pharmaceutical Co., Ltd gets an overall score of 4/5.
| Industry | Drug Manufacturers-Specialty & Generic |
|---|---|
| Sector | Healthcare |
| CurrencyCode | CNY |
| Exchange | SHE |
| ISIN | CNE1000011T7 |
| Dividend Yield | 0.0% |
|---|---|
| Target Price | 15.05 |
| PE Ratio | 0.0 |
| Beta | 0.77 |
| Market Cap | 10B |
Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of therapeutic peptides API and polypeptide drugs in China and internationally. The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix and atosiban for obstetrics and gynecology, etc; customized peptides; working standards for the peptide APIs and related impurities, to facilitate your project in an all-round way; CRO services; and platform for CDMO services, which includes peptide API synthesis and purification process development, finish dosage form development, reference standard preparation and qualification, impurity and product quality study and analysis, GMP system meeting EU and FDA standard, international and Chinese regulatory and dossier support, etc. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300199.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
